Kalivir Immunotherapeutics has a total of 71 patents globally, out of which no patent has been granted. Of these 71 patents, more than 92% patents are active. The United States of America is where Kalivir Immunotherapeutics has filed the maximum number of patents, followed by Australia and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Kalivir Immunotherapeutics.
Kalivir Immunotherapeutics was founded in 2019. The company develops oncolytic vaccinia platform for enhanced intravenous delivery, targeted tumor replication, and spread within the tumor environment. Their system offers tailored transgene programs with proprietary genetic modifications for advanced oncolytic viral immunotherapy.
Do read about some of the most popular patents of Kalivir Immunotherapeutics which have been covered by us in this article and also you can find Kalivir Immunotherapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kalivir Immunotherapeutics patent portfolio.
How many patents does Kalivir Immunotherapeutics have?
Kalivir Immunotherapeutics has a total of 71 patents globally. These patents belong to 9 unique patent families. Out of 71 patents, 66 patents are active.
How Many Patents did Kalivir Immunotherapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Kalivir Immunotherapeutics Applications Filed | Kalivir Immunotherapeutics Patents Granted |
| 2023 | 13 | – |
| 2022 | 18 | – |
| 2021 | 18 | – |
| 2020 | 14 | – |
| 2019 | 3 | – |
| 2018 | 5 | – |
How many Kalivir Immunotherapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Kalivir Immunotherapeutics File in Different Countries?
Countries in which Kalivir Immunotherapeutics Filed Patents
| Country | Patent |
| United States Of America | 12 |
| Australia | 8 |
| Canada | 8 |
| Europe | 7 |
| Hong Kong (S.A.R.) | 4 |
| South Africa | 3 |
| Singapore | 3 |
| Taiwan | 3 |
| Israel | 3 |
| New Zealand | 3 |
| Colombia | 2 |
| Mexico | 2 |
| Costa Rica | 1 |
| Brazil | 1 |
| Chile | 1 |
| Dominican Republic | 1 |
| Viet Nam | 1 |
| Peru | 1 |
| Ecuador | 1 |
| Eurasian Patent Organization | 1 |
Where are Research Centers of Kalivir Immunotherapeutics Patents Located?
What Percentage of Kalivir Immunotherapeutics US Patent Applications Were Granted?
Kalivir Immunotherapeutics (Excluding its subsidiaries) has filed 9 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these no patent has been granted leading to a grant rate of 0%.
Below are the key stats of Kalivir Immunotherapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Kalivir Immunotherapeutics?
| Law Firm | Total Applications | Success Rate |
| Greenberg Traurig Llp | 9 | 0% |
What are Kalivir Immunotherapeutics key innovation segments?
What Technologies are Covered by Kalivir Immunotherapeutics?
The chart below distributes patents filed by Kalivir Immunotherapeutics